You could profit %53 with $AVDL by Preticks : Avadel Pharmaceuticals Announces Positive Topline Results from its Pivotal Phase 3 REST-ON Trial of Once-Nightly FT218 for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Patients with Narcolepsy 
#StockMarket #stocks https://t.co/PwPZND6bvb